头颈癌放疗实时同行评审质量保证查房的前瞻性定性与定量分析
本研究前瞻性纳入85例接受头颈癌调强放疗(IMRT)的患者,在模拟定位和勾画后参加每两周一次的同行评审质量保证门诊。结果显示,12例(14%)患者因体检发现新临床体征而计划发生重大改变;CTV1的Dice相似系数(DSC)显著优于CTV2和CTV3;中位随访38个月后仅10例(12%)出现局部或区域复发,多位于中心高剂量区。结论认为综合同行评审门诊是IMRT质量保证的重要组成部分。
要点
- 体检发现新临床体征导致14%患者计划重大改变。
- CTV1的DSC为0.94±0.10,显著优于CTV2和CTV3。
- 中位随访38个月,仅12%出现局部或区域复发。
核心结论
- 综合同行评审计划门诊是IMRT质量保证的重要组成部分,使约三分之一研究人群的计划发生重大改变。
- 该流程确保了靶区定义相关的安全性,并带来良好的疾病控制,未发现可归因于几何脱靶或勾画错误的复发。
研究设计与样本
- 前瞻性收集85例接受头颈癌IMRT患者的资料,患者在模拟定位和勾画后参加每两周一次的质量保证门诊。
- 所有85例患者均由至少1名非治疗主治医生的头颈亚专科放射肿瘤学家检查,其中80例(94%)由≥3名教员检查。
- 采用标准数据收集表记录流程中的修改,比较质量保证前主治医生批准的临床靶体积(CTV)与质量保证后共识CTV,计算Dice相似系数(DSC)等体积重叠指标,并按重叠程度将改变分类为重大、次要和轻微。
主要发现
- 12例患者(14%)体检发现新临床体征,导致计划重大改变。
- 定量DSC分析显示CTV1(0.94±0.10)的勾画一致性显著优于CTV2(0.82±0.25)和CTV3(0.86±0.2)(分别为P=.0002和P=.03;配对Wilcoxon检验)。
- 考虑所有CTV水平时,治疗主治放射肿瘤医生的经验显著影响DSC值(P=.012;配对Wilcoxon检验)。
- 中位随访38个月后,仅10例患者(12%)出现局部复发、区域复发或两者兼有,且多位于中心高剂量区。
临床怎么用
- 在头颈癌IMRT流程中纳入实时同行评审质量保证门诊,由非治疗主治医生的头颈亚专科放射肿瘤学家参与,以发现体检新体征并优化靶区勾画。
- 利用DSC等定量指标评估CTV勾画一致性,关注CTV2和CTV3等一致性较低的区域以及主治医生经验对勾画的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our department has a long-established comprehensive quality assurance (QA) planning clinic for patients undergoing radiation therapy (RT) for head and neck cancer. Our aim is to assess the impact of a real-time peer review QA process on the quantitative and qualitative radiation therapy plan changes in the era of intensity modulated RT (IMRT). METHODS AND MATERIALS: Prospective data for 85 patients undergoing head and neck IMRT who presented at a biweekly QA clinic after simulation and contouring were collected. A standard data collection form was used to document alterations made during this process. The original pre-QA clinical target volumes (CTVs) approved by the treating-attending physicians were saved before QA and compared with post-QA consensus CTVs. Qualitative assessment was done according to predefined criteria. Dice similarity coefficients (DSC) and other volume overlap metrics were calculated for each CTV level and were used for quantitative comparison. Changes are categorized as major, minor, and trivial according to the degree of overlap. Patterns of failure were analyzed and correlated to plan changes. RESULTS: All 85 patients were examined by at least 1 head and neck subspecialist radiation oncologist who was not the treating-attending physician; 80 (94%) were examined by ≥3 faculty members. New clinical findings on physical examination were found in 12 patients (14%) leading to major plan changes. Quantitative DSC analysis revealed significantly better agreement in CTV1 (0.94 ± 0.10) contours than in CTV2 (0.82 ± 0.25) and CTV3 (0.86 ± 0.2) contours (P=.0002 and P=.03, respectively; matched-pair Wilcoxon test). The experience of the treating-attending radiation oncologist significantly affected DSC values when all CTV levels were considered (P=.012; matched-pair Wilcoxon text). After a median follow-up time of 38 months, only 10 patients (12%) had local recurrence, regional recurrence, or both, mostly in central high-dose areas. CONCLUSIONS: Comprehensive peer review planning clinic is an essential component of IMRT QA that led to major changes in one-third of the study population. This process ensured safety related to target definition and led to favorable disease control profiles, with no identifiable recurrences attributable to geometric misses or delineation errors.
引用
- Cardenas CE, Mohamed ASR, Tao R, et al. Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016. PMID: 28258898. doi:10.1016/j.ijrobp.2016.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。